TY  - GEN
AU  - Choueiri,Toni K
AU  - Vaziri,Susan A J
AU  - Jaeger,Erich
AU  - Elson,Paul
AU  - Wood,Laura
AU  - Bhalla,Ish Prasad
AU  - Small,Eric J
AU  - Weinberg,Vivian
AU  - Sein,Nancy
AU  - Simko,Jeff
AU  - Golshayan,Ali-Reza
AU  - Sercia,Linda
AU  - Zhou,Ming
AU  - Waldman,Frederic M
AU  - Rini,Brian I
AU  - Bukowski,Ronald M
AU  - Ganapathi,Ram
TI  - von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma
SN  - 1527-3792
PY  - 2008///0918
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Axitinib
KW  - Benzenesulfonates
KW  - Bevacizumab
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Chi-Square Distribution
KW  - DNA Primers
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Indazoles
KW  - Indoles
KW  - Kidney Neoplasms
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - genetics
KW  - Neoplasm Metastasis
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Prognosis
KW  - Pyridines
KW  - Pyrroles
KW  - Sorafenib
KW  - Sunitinib
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - von Hippel-Lindau Disease
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.juro.2008.05.015
ER  -